{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 396722627
| IUPAC_name = (11β)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3,20-dioxopregna-1,4-dien-21-yl propionate
| image = Prednicarbat Structure V.1.svg
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|monograph|prednicarbate}}
| MedlinePlus = a604021
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration = [[外用藥物|外用藥物]]
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| IUPHAR_ligand = 7605
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 73771-04-7
| ATC_prefix = D07
| ATC_suffix = AC18
| ATC_supplemental =  
| PubChem = 6714002
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB01130
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = V901LV1K7D
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200386
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 5145991
| smiles = O=C(OCC(=O)[C@@]1(OC(=O)OCC)CC[C@H]2[C@H]4[C@H]([C@@H](O)C[C@]12C)[C@]/3(/C=C\C(=O)\C=C\3CC4)C)CC
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C27H36O8/c1-5-22(31)34-15-21(30)27(35-24(32)33-6-2)12-10-19-18-8-7-16-13-17(28)9-11-25(16,3)23(18)20(29)14-26(19,27)4/h9,11,13,18-20,23,29H,5-8,10,12,14-15H2,1-4H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = FNPXMHRZILFCKX-KAJVQRHHSA-N
<!--Chemical data-->
| C=27 | H=36 | O=8
| molecular_weight = 488.57 g/mol
| synonyms = <small>[2-[(8''S'',9''S'',10''R'',11''S'',13''S'',14''S'',17''R'')-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6''H''-cyclopenta[''a'']phenanthren-17-yl]-2-oxoethyl] propanoate</small>
}}
{{medical}}
'''潑尼卡酯'''是一种新型[[外用藥物|外用藥物]]，属于[[皮質類固醇|皮質類固醇]]，其药效与[[皮質醇|皮質醇]]类似。和其他局部用皮質類固醇（如[[倍他米松|倍他米松]]）相比，重复使用潑尼卡酯不会很快导致[[皮膚|皮膚]][[萎縮|萎縮]]。{{Citation needed|date=September 2008}}皮質類固醇向来是治疗[[皮肤病学|皮肤病学]]的药理学重要储备之一，但由于它可能会产生副作用，所以还需要探索新的药剂。

潑尼卡酯未被卤化<ref name="pmid15657633">{{cite journal |vauthors=Gupta AK, Chow M |title=A review of prednicarbate (Dermatop) |journal=Skin Therapy Lett. |volume=9 |issue=10 |pages=5–6, 9 |year=2004 |pmid=15657633 |doi= |url=http://www.skintherapyletter.com/2004/9.10/2.html |access-date=2016-11-16 |archive-date=2018-01-09 |archive-url=https://web.archive.org/web/20180109042545/http://www.skintherapyletter.com/2004/9.10/2.html |dead-url=yes }}</ref>。

==  参考文献==
{{Reflist|2}}

{{dermatologic-drug-stub}}

[[Category:皮质类固醇|Category:皮质类固醇]]
[[Category:丙酸酯|Category:丙酸酯]]
[[Category:碳酸酯|Category:碳酸酯]]